These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients. Boero R, Degli Esposti E, Fabbri A, Guarena C, Forneris G, Quarello F, Fusaroli M, Piccoli G. Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312 [Abstract] [Full Text] [Related]
4. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy. Boero R, Fabbri A, Degli Esposti E, Guarena C, Forneris G, Lucatello A, Sturani A, Quarello F, Fusaroli M, Piccoli G. Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021 [Abstract] [Full Text] [Related]
5. Abnormal sodium-lithium countertransport kinetics in immunoglobulin A nephropathy patients and the families: association with hypertension. Ho KL, Rutherford PA, Thomas TH, Wilkinson R. Am J Kidney Dis; 1996 Mar; 27(3):334-40. PubMed ID: 8604701 [Abstract] [Full Text] [Related]
6. [Activity of sodium-lithium cotransport in erythrocytes of patients with diabetes mellitus type I (IDDM) complicated by diabetic nephropathy in the renal failure stage]. Trelewicz P, Gumprecht J, Zukowska-Szczechowska E, Grzeszczak W, Moczulski D, Liszka M. Pol Arch Med Wewn; 1997 Jun; 97(6):527-33. PubMed ID: 9441288 [Abstract] [Full Text] [Related]
7. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension. Thomas TH, Rutherford PA, West IC, Wilkinson R. Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199 [Abstract] [Full Text] [Related]
8. Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients. Dowd A, Thomas TH, Taylor R, Wilkinson R. Diabetologia; 1994 Apr; 37(4):394-400. PubMed ID: 8063041 [Abstract] [Full Text] [Related]